NEW YORK, Sept. 3, 2015 /PRNewswire/ -- The findings of a year-long investigation conducted by NBC Nightly News are raising disturbing questions about the company's handling of its Recovery IVC filter product Bernstein Liebhard LLP reports. On September 2nd, part one of the series revealed that more than 300 adverse events, including at least 27 fatalities, have been associated with the Recovery device. NBC News also disclosed a confidential study commissioned by C.R. Bard in 2004 which linked the Recovery IVC filter to higher rates of death, fracture and movement compared to its competitors. While the author of the report asserted that "further investigation" of the matter was "urgently warranted," C.R. Bard opted not to recall the product. For nearly three years, the company would sell roughly 34,000 Recovery filters before replacing it with a modified version sold under a different name.
"Our Firm has been contacted by a number of Recovery filter patients who claim to have suffered complications similar to those discussed in the NBC Nightly News report. We are pleased that the network is bringing attention to this important public health issue, and we are eager to learn what else the investigation revealed when part two airs this evening," says Sandy A. Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently investigating product liability claims on behalf of individuals who may have been harmed by C.R. Bard's IVC filters.
C.R. Bard IVC Filter Lawsuits
IVC filters, such as C.R. Bard's Recovery device, are intended to be implanted in the inferior vena cava in order to block blood clots from traveling to the lungs. In 2005 the company replaced the Recovery filter with the G2 IVC Filter system. Both are retrievable filters, and are intended to be removed once the danger of blood clots has passed.
In 2010, the U.S. Food & Drug Administration (FDA) disclosed that retrievable IVC filters had been associated with more than 900 adverse events, including incidents of migration, fracture and embolization, and perforation of the inferior vena cava. In 2014, the agency issued a new advisory to remind doctors that retrievable IVC filters should be removed within 29 to 54 days of their implantation. However, a study that appeared in JAMA: Internal Medicine in April 2013 suggested that successful IVC retrieval occurred in only 10% of patients.
Court documents indicate that C.R. Bard has been named in dozens of IVC filter lawsuits, all of which claim that the Recovery and G2 products are prone to fracture, migrate, tilt or perforate the inferior vena cava, resulting in serious injury to patients. On August 17th, the U.S. Judicial Panel on Multidistrict Litigation transferred all federally filed C.R. Bard IVC filter cases to the U.S. District Court, District of Arizona for the purposes of coordinated pretrial proceedings. (In Re: Bard IVC Filters Products Liability Litigation – MDL No. 2641)
Individuals who allegedly experienced serious complications due to C.R. Bard's Recovery and G2 IVC filters may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a C.R. Bard IVC filter lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can also be obtained by calling 800-511-5092.
About Bernstein Liebhard LLP Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.
Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016 800-511-5092